KCNJ11 and dyslexia: Additionally, patients with activating variants in KCNJ11 may present with attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), anxiety disorders, sleep difficulties, developmental coordination disorder (DCD), delays in learning, diminished intelligence quotient (IQ), and dyslexia (1, 14, 17–19).